CYTOKINE MODULATION IN CARDIAC SURGERY: CASE SERIES

Аim. Extracorporeal circulation, temporary aortic cross-clamping, cardioplegic arrest, perioperative heart failure, and comorbidities all are among the leading risk factors of a systemic inflammatory response syndrome (SIRS), which in some cases progresses to multiple organ failure (MOF). It has been recently suggested that sorption of inflammatory mediators using selective cytokine sorbents can prevent the development of MOF. We tested the efficacy of interleukin-6 (IL-6) sorption in pa-tients who underwent coronary artery bypass graft surgery requiring extracorporeal circulation with the subsequent development of sepsis (n = 9) and patients who was subjected to preventive adsorption during perfusion (n = 3). Materials and Methods. In addition to stan-dard clinical and biochemical parameters, we measured levels of serum IL-6 prior to the procedure, after the procedure and 24 hours after the sorption.Results. We noted a decrease in norepinephrine support and serum IL-6 as well as regression of MOF severity, particularly in patients with a preventive adsorption during the perfusion.Conclusions. IL-6 sorption is a promising method for correcting SIRS and MOF in patients who underwent coronary artery bypass graft sur-gery, particularly if applied in a preventive manner during the perfusion.

искусственное кровообращение, кардиохирургия, сорбция цитокинов, системный воспалительный ответ, сепсис, полиорганная недостаточность, extracorporeal circulation, сardiac surgery, cytokine adsorption, systemic inflammatory response, sepsis, multiorgan failure

1. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis. 2008; 8 (1): 32-43. doi: 10.1016/S1473-3099(07)70265-7

2. Tomic V, Russwurm S, Möller E, Claus RA, Blaess M, Brunkhorst F, et al. Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation. 2005; 112 (19): 2912-2920. doi: 10.1161/CIRCULATIONAHA.104.531152

3. Chew MS, Brandslund I, Brix-Christensen V, Ravn HB, Hjortdal VE, Pedersen J, et al. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology. 2001; 94 (5): 745-753

4. Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017; 39 (5): 517-528. doi: 10.1007/s00281-017-0639-8

5. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inammatory responses to injury. Nature. 2010; 464 (7285): 104-107. doi: 10.1038/nature08780

6. Harris HE, Raucci A. Alarmin(g) news about danger : Workshop on innate danger signals and HMGB1. EMBO Rep. 2006; 7 (8): 774-778. doi:10.1038/sj.embor.7400759

7. Schaefer L. Complexity of danger: The diverse nature of damage-associated molecular patterns. J Biol Chem. 2014; 289 (51): 35237-35245. doi: 10.1074/jbc.R114.619304

8. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007; 81 (1): 1-5. Doi: 10.1189/jlb.0306164

9. Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence. 2014; 5 (1): 36-44. Doi: 10.4161/viru.25436

10. de Lange DW, Bonten MJM. Can we predict septic shock in patients with hospital-acquired pneumonia? Crit Care. 2005; 9 (6): 640-641. doi: 10.1186/cc3919

11. Rimmelé T, Kellum JA. Clinical review: blood purification for sepsis. Crit Care. 2011; 15 (1): 205. doi: 10.1186/cc9411

12. Hinz B, Jauch O, Noky T, Friesecke S, Abel P, Kaiser R. CytoSorb, a novel therapeutic approach for patients with septic shock: a case report. Int J Artif Organs. 2015; 38 (8): 461-464. doi: 10.5301/ijao.5000429

13. Born F, Pichlamier M, Peter S. Systemic inflammatory response syndrome in heart surgery: New possibilities for treatment through the use of a cytokine adsorber during ECC? Kardiotechnik. 2014; 2: 1-10

14. Träger K, Fritzler D, Fischer G, Schröder J, Skrabal C, Liebold A, et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs. 2016; 39 (3): 141-146. doi: 10.5301/ijao.5000492

15. Ito T. PAMPs and DAMPs as triggers for DIC. J Intensive Care. 2014; 2 (1): 67. doi: 10.1186/s40560-014-0065-0

16. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007; 167 (15): 1655-1663. doi: 10.1001/archinte.167.15.1655

17. Putzu A, Fang MX, Boscolo BM, Belletti A, Cabrini L, Cassina T, et al. Blood purification with continuous veno-venous hemofiltration in patients with sepsis or ARDS: a systematic review and meta-analysis. Minerva Anestesiol. 2017; 83 (8): 867-877. doi: 10.23736/S0375-9393.17.11946-2

18. Villa G, Zaragoza JJ, Sharma A, Neri M, De Gaudio AR, Ronco C. Cytokine removal with high cut-off membrane: review of literature. Blood Purif. 2014; 38 (3-4): 167-173. doi: 10.1159/000369155

19. Shum HP, Yan WW, Chan TM. Extracorporeal blood purification for sepsis. Hong Kong Med J. 2016; 22 (5): 478-485. doi: 10.12809/hkmj164876

20. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappa B DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med. 2004; 32 (3): 801-805

21. Peng ZY, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008; 36 (5): 1573-1577. doi 10.1097/CCM.0b013e318170b9a7

22. Peng Z-Y, Wang H-Z, Carter MJ, Dileo MV, Bishop JV, Zhou F-H, et al. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int. 2012; 81 (4): 363-369. doi: 10.1038/ki.2011.320

23. Gruda MC, Ruggeberg K-G, O'Sullivan P, Guliashvili T, Scheirer AR, Golobish TD, et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS One. 2018; 13 (1): e0191676. doi: 10.1371/journal.pone.0191676

24. David S, Ghosh CC, Mukherjee A, Parikh SM. Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote endothelial barrier defense. Arterioscler Thromb Vasc Biol. 2011; 31 (11): 2643-2652. doi: 10.1161/ATVBAHA.111.233189

25. Friesecke S, Träger K, Schittek GA, Molnar Z, Bach F, Kogelmann K, et al. International registry on the use of the CytoSorb® adsorber in ICU patients. Study protocol and preliminary results. Med Klin Intensivmed Notfmed. 2017. Epub ahead of print. doi: 10.1007/s00063-017-0342-5

26. Rimmele T, Kellum JA. Clinical review: blood purification for sepsis. Crit Care. 2011; 15 (1): 205. doi: 10.1186/cc9411

27. Tarakcioglu M, Erbagci AB, Usalan C, Deveci R, Kocabas R. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. Mediators Inflamm. 2003; 12 (1): 15-19. doi: 10.1080/0962935031000096935

28. Joannes-Boyau O, Honore PM, Perez P, Bagshaw SM, Grand H, Canivet JL, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med. 2013; 39 (9): 1535-1546. doi: 10.1007/s00134-013-2967-z

29. Kruttgen A, Rose-John S. Interleukin-6 in sepsis and capillary leakage syndrome. J Interferon Cytokine Res. 2012; 32 (2): 60-65. doi: 10.1089/jir.2011.0062

30. David S, Thamm K, Schmidt BMW, Falk CS, Kielstein JT. Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient. J Intensive Care. 2017; 5: 12. doi: 10.1186/s40560-017-0208-1

31. Kovach MA, Standiford TJ. The function of neutrophils in sepsis. Curr Opin Infect Dis. 2012; 25 (3): 321-327. doi: 10.1097/QCO.0b013e3283528c9b

32. Antonopoulou A, Giamarellos-Bourboulis EJ. Immunomodulation in sepsis: state of the art and future perspective. Immunotherapy. 2011; 3 (1): 117-128. doi: 10.2217/imt.10.82

33. Hara Y, Shimomura Y, Nakamura T, Kuriyama N, Yamashita C, Kato Y, et al. Novel blood purification system for regulating excessive immune reactions in severe sepsis and septic shock: an ex vivo pilot study. Ther Apher Dial. 2015; 19 (4): 308-315. doi: 10.1111/1744-9987.12338

34. Ma S, Xu Q, Deng B, Zheng Y, Tian H, Wang L, et al. Granulocyte and monocyte adsorptive apheresis ameliorates sepsis in rats. Intensive Care Med Exp. 2017; 5 (1): 18. doi: 10.1186/s40635-017-0129-2

35. Барбараш Л.С., Шукевич Д.Л., Плотников Г.П., Хаес Б.Л., Стасев А.Н., Кокорин С.Г. и др. Концепция пациент-ориентированного перфузионно-анестезиологического обеспечения при репротезировании клапанов сердца // Кардиология и сердечно-сосудистая хирургия. 2017; 10 (3): 4-10

36. Барбараш Л.С., Григорьев Е.В., Плотников Г.П., Шукевич Д.Л., Шукевич Л.Е. Гемодинамика и гидродинамический статус в течение заместительной почечной терапии при системном воспалительном ответе инфекционной и неинфекционной этиологии // Комплексные проблемы сердечно-сосудистых заболеваний. 2012; 2: 39-44